Clinical trial
A Double-Blind Placebo-Controlled Multi-Site Randomized Cross-Over Study of the Effectiveness and Efficacy of the PowerSleep Device
NCT03162328 is registered in ClinicalTrials.gov with Philips Respironics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind Placebo-Controlled Multi-Site Randomized Cross-Over Study of the Effectiveness and Efficacy of the PowerSleep Device
- Lead sponsor
- Philips Respironics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 25, 2017
- Completion date
- November 10, 2017
- Enrollment
- 84 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, insufficient sleep syndrome, sleep deprivation